Tilda Barliya

BACKGROUND: T cells play a central role in the antitumor response. However, they often face numerous hurdles in the tumor microenvironment, including the scarcity of available essential metabolites such as glucose and amino acids. Moreover, cancer cells can monopolize these resources to thrive and proliferate by upregulating metabolite transporters and maintaining a high metabolic rate, thereby outcompeting T cells.

Immune cell therapies and immune cell engineering Genetically engineering glycolysis in T cells increases their antitumor function Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

2023 Update from LPBI Group February 21, 2022 by 2012pharmaceutical 2023 Update from LPBI Group Author & Curator: Aviva Lev-Ari, PhD, RN Picture on 2/6/2022 BIO https://pharmaceuticalintelligence.com/knowledge-portals-system-kps/aviva-lev-ari-phd-rn-founder-lpbi-group-1-0-2-0/ UPDATED on 2/12/2023 Prediction of Page downloads from 18 volumes in BioMed e-Series All volumes since date of publication on 1/1/2023: 137,000 Total for Series A: 2022 37,818 Total for Series A: 2023 43,691 Total for...